全文获取类型
收费全文 | 7437篇 |
免费 | 549篇 |
国内免费 | 1374篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 29篇 |
妇产科学 | 64篇 |
基础医学 | 418篇 |
口腔科学 | 89篇 |
临床医学 | 832篇 |
内科学 | 1437篇 |
皮肤病学 | 86篇 |
神经病学 | 335篇 |
特种医学 | 546篇 |
外国民族医学 | 4篇 |
外科学 | 1651篇 |
综合类 | 1967篇 |
预防医学 | 235篇 |
眼科学 | 122篇 |
药学 | 626篇 |
6篇 | |
中国医学 | 247篇 |
肿瘤学 | 562篇 |
出版年
2024年 | 2篇 |
2023年 | 115篇 |
2022年 | 183篇 |
2021年 | 322篇 |
2020年 | 333篇 |
2019年 | 225篇 |
2018年 | 251篇 |
2017年 | 199篇 |
2016年 | 230篇 |
2015年 | 269篇 |
2014年 | 619篇 |
2013年 | 575篇 |
2012年 | 720篇 |
2011年 | 720篇 |
2010年 | 601篇 |
2009年 | 554篇 |
2008年 | 417篇 |
2007年 | 543篇 |
2006年 | 370篇 |
2005年 | 302篇 |
2004年 | 358篇 |
2003年 | 385篇 |
2002年 | 278篇 |
2001年 | 198篇 |
2000年 | 151篇 |
1999年 | 160篇 |
1998年 | 58篇 |
1997年 | 65篇 |
1996年 | 25篇 |
1995年 | 18篇 |
1994年 | 17篇 |
1993年 | 22篇 |
1992年 | 25篇 |
1991年 | 14篇 |
1990年 | 14篇 |
1989年 | 10篇 |
1988年 | 1篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1984年 | 1篇 |
1983年 | 1篇 |
排序方式: 共有9360条查询结果,搜索用时 31 毫秒
1.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(5):681-690
BackgroundThe American Joint Committee on Cancer (AJCC) made improvements for staging pancreatic neuroendocrine tumors (pNETs) in its 8th Edition; however, multicenter studies were not included.MethodsWe collected multicenter datasets (n = 1,086, between 2004 and 2018) to validate the value of AJCC 8 and other coexisting staging systems through univariate and multivariate analysis for well-differentiated (G1/G2) pNETs.ResultsCompared to other coexisting staging systems, AJCC 7 only included 12 (1.1%) patients with stage III tumors. Patients with European Neuroendocrine Tumor Society (ENETS) stage IIB disease had a higher risk of death than patients with stage IIIA (hazard ratio [HR]: 4.376 vs. 4.322). For the modified ENETS staging system, patients with stage IIB disease had a higher risk of death than patients with stage III (HR: 6.078 vs. 5.341). According to AJCC 8, the proportions of patients with stage I, II, III, and IV were 25.7%, 40.3%, 23.6%, and 10.4%, respectively. As the stage advanced, the median survival time decreased (NA, 144.7, 100.8, 72.0 months, respectively), and the risk of death increased (HR: II = 3.145, III = 5.925, and IV = 8.762).ConclusionThese findings suggest that AJCC 8 had a more reasonable proportional distribution and the risk of death was better correlated with disease stage. 相似文献
2.
3.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
4.
5.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2020,30(10):1732-1741
AimsTo explore the association between WWI and the incidence of HTN in the Rural Chinese Cohort Study.Methods and ResultsWe examined data for 10,338 non-hypertensive participants (39.49% men) aged ≥ 18 years from the Rural Chinese Cohort Study who completed a baseline examination during 2007–2008 and follow-up during 2013–2014. WWI was calculated as waist circumference (cm) divided by the square root of weight (kg). Multiple logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the probability of HTN across four WWI categories. Restricted cubic splines analysis was used to model the dose–response association of WWI and HTN. A total of 2078 participants had HTN during a median follow-up of 6 years. After adjusting for potential confounders, as compared with the lowest WWI category (<9.94 cm/√kg), with WWI 9.94 to 10.42, 10.42 to 10.91 and ≥ 10.91 cm/√kg, the ORs (95% CIs) for HTN were 1.12 (0.93–1.35), 1.40 (1.17–1.69) and 1.50 (1.24–1.82), respectively. Results of the sensitivity analyses were robust. The ORs were generally consistent on subgroup analysis by sex, smoking status, systolic blood pressure and diastolic blood pressure. Multiple logistic regression models with restricted cubic splines showed a non-linear positive association between WWI and HTN (Pnonlinearity < 0.001).ConclusionThe highest WWI category was significantly associated with increased risk of HTN. Our findings may facilitate the development and promotion of obesity prevention strategies aimed at reducing the risk of HTN and provide evidence for healthcare policy in rural China. 相似文献
6.
7.
8.
Ye Gao Lei Xin Yu-Xin Wang Yuan-Hang Dong Zhuan Liao 《Scandinavian journal of gastroenterology》2020,55(1):105-113
AbstractBackground and aim: Capsule retention is the most common adverse event associated with video capsule endoscopy. The use of double-balloon enteroscopy-assisted capsule endoscope retrieval has been increasingly reported in recent years. However, evidence is limited regarding its success rate, associated factors, and subsequent clinical outcomes.Methods: A systematic review of relevant studies published before January 2019 was performed. Successful retrieval rate and associated factors, rate of endoscopic balloon dilation, and outcomes after double-balloon enteroscopy were summarized and pooled.Results: Within 154 associated original articles, 12 including 150 cases of capsule retrieval by double-balloon enteroscopy were included. The estimated pooled successful retrieval rate was 86.5% (95% confidence interval, 75.6–95.1%). Anterograde approach and capsules retained in the jejunum or trapped by malignant strictures were associated with a higher successful retrieval rate than the retrograde approach (62/83 [74.7%] vs. 10/38 [26.3%], p?<?.001) and capsules retained in the ileum (41/41 [100.0%] vs. 43/58 [74.1%], p?<?.001) or trapped by benign strictures (21/21 [100.0%] vs. 65/83 [78.3%], p?=?.043). Endoscopic balloon dilation was performed in 38.8% (95% confidence interval, 22.3–56.3%) of patients with benign strictures. Two perforations (1.3%) were reported as severe adverse events after double-balloon enteroscopy. A significantly lower surgery rate was found among cases with successful video capsule removal compared with unsuccessful cases (7.2% vs. 38.5%, p?=?.002).Conclusions: Double-balloon enteroscopy is feasible and safe for removing retained video capsule endoscopes, and its use could decrease the need for surgery in patients with benign strictures and facilitate subsequent surgery in patients with malignant strictures. 相似文献
9.
Fas/FasL在各阶段婴幼儿血管瘤中的表达及意义 总被引:15,自引:0,他引:15
目的 检测Fas/FasL在各阶段婴幼儿血管瘤组织中的表达,探讨Fas/FasL在婴幼儿血管瘤细胞凋亡中的作用。方法 应用EnVision法免疫组化染色和RT-PCR检测Fas/FasL蛋白及mRNA在各阶段血管瘤组织中的表达。结果 ①增生早期和增生中期,部分血管瘤细胞表达Fas;增生晚期,阳性细胞明显增多,Fas mRNA表达最强;消退早期,仍有少量微血管内皮细胞表达Fas,之后Fas表达迅速减弱。②最早期细胞团中没有FasL(+)细胞;增生中期,血管瘤组织中出现少量FasL(+)细胞;增生晚期FasL(+)细胞显著增多,FasL mRNA表达最强;消退早期之后,FasL(+)细胞迅速减少以至消失。结论 Fas/FasL与婴幼儿血管瘤演变过程有密切联系,Fas/FasL介导的血管瘤细胞凋亡可能是婴幼儿血管瘤自行消退的重要原因。 相似文献
10.
未控制出血性休克与TNF—a的关联性及不同液体复苏的作用 总被引:1,自引:0,他引:1
目的 研究未控制出血性休克时不同液体复苏的作用以及,INF—a的变化规律,以期阐明限制性液体复苏降低未控制出血性休克的死亡率和改善预后的相关机制。方法采用改良后的Krausz方法建立重度脾创伤未控制出血性休克大鼠模型。采用随机分组的原则将大鼠分为假处理组、限制输液组、常规输液组、不输液组。观察各组动物的出血量、输液量、存活率、存活时间及各时间点的血压、血细胞比容(Hct)和TNF—a的变化情况。结果①限制输液组的输液量明显少于常规输液组(P〈0.05),出血量也明显少于常规输液组(P〈0.05)。②限制输液组Hct明显高于常规输液组(P〈0.05)。②限制输液组的存活时间比常规输液组及不输液组明显延长(P均〈0.05)。限制输液组在72h内的存活率明显高于常规输液组和不输液组。但低于假处理组(P均〈0.1)。④除假处理组外其余各组在伤后90min和180min血TNF—a水平均较伤前均有明显升高(P均〈0.05);常规输液组,TNF—a水平明显高于限制输液组(P〈0.05)。⑤死亡者TNF—a水平明显高于生存者。结论本研究结果表明,在重度未控制出血条件下,限制性液体复苏可明显降低出血量,提高存活率。未控制性出血休克时的TNF—a水平与预后密切相关,TNF—a高预后不良,而限制性液体复苏时TNF—a水平明显降低。 相似文献